Hit me with your best shot: dolutegravir - a space in the next WHO guidelines?

AIDS. 2015 Oct 23;29(16):2067-70. doi: 10.1097/QAD.0000000000000813.

Authors

Jennifer Cohn¹, Linda-Gail Bekker, Helen Bygrave, Alexandra Calmy

Affiliation

¹ aMédecins Sans Frontières Access Campaign, Geneva, Switzerland bThe Desmond Tutu HIV Centre, University of Cape Town, Republic of South Africa cHIV Unit, Department of Internal Medicine, Geneva University Hospital, Geneva, Switzerland.

PMID: 26544574
DOI: 10.1097/QAD.0000000000000813

No abstract available

MeSH terms

Antiretroviral Therapy, Highly Active / methods*
Clinical Trials as Topic
HIV Infections / drug therapy*
HIV Integrase Inhibitors / administration & dosage*
Heterocyclic Compounds, 3-Ring / administration & dosage*
Humans
Oxazines
Piperazines
Pyridones
Treatment Outcome

Substances

HIV Integrase Inhibitors
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
dolutegravir